Polymer-Functionalized Nanodiamond Platforms as Vehicles for Gene Delivery
Source abstract
Abstract
Gene therapy holds great promise for treating diseases ranging from inherited disorders to acquired conditions and cancers. Nonetheless, because a method of gene delivery that is both effective and safe has remained elusive, these successes were limited. Functional nanodiamonds (NDs) are rapidly emerging as promising carriers for next-generation therapeutics with demonstrated potential. Here we introduce NDs as vectors for in vitro gene delivery via surface-immobilization with 800 Da polyethyleneimine (PEI800) and covalent conjugation with amine groups. We designed PEI800-modified NDs exhibiting the high transfection efficiency of high molecular weight PEI (PEI25K), but without the high cytotoxicity inherent to PEI25K. Additionally, we demonstrated that the enhanced delivery properties were exclusively mediated by the hybrid ND-PEI800 material and not exhibited by any of the materials alone. This platform approach represents an efficient avenue toward gene delivery via DNA-functionalized NDs, and serves as a rapid, scalable, and broadly applicable gene therapy strategy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Diamond and Carbon-based Materials Research · Force Microscopy Techniques and Applications · Ion-surface interactions and analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomedical Engineering,
Department of Biological Sciences,
Department of Chemistry, and
Department of Mechanical Engineering, Northwestern University, Evanston, Illinois 60208
NanoCarbon Research Institute, Shinshu University, Ueda, Nagano 386-8567, Japan
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois 60611
References (50)
Show source-provided references
1. Salem A. K. · Nat. Mater. · 2003 · 2 · 66810.1038/nmat974 ↗
2. Gene Therapy Clinical Trials Worldwide provided by the Journal of Gene Medicine. 2007, www.wiley.co.uk/genmed/clinical/.
3. Hollon T. · Nat. Med. · 2000 · 6 · 610.1038/71545 ↗
4. Check E. · Nature · 2005 · 433 · 561
5. Pouton C. W. · Adv. Drug Delivery Rev. · 2001 · 46 · 18710.1016/S0169-409X(00)00133-2 ↗
6. Green J. J. · Acc. Chem. Res. · 2008 · 41 · 74910.1021/ar7002336 ↗
7. Thomas M. · Proc. Natl. Acad. Sci. U.S.A · 2003 · 100 · 913810.1073/pnas.1233634100 ↗
8. Liu K. K. · Nanotechnology · 2007 · 18 · 32510210.1088/0957-4484/18/32/325102 ↗
9. Kruger A. · J. Mater. Chem. · 2006 · 16 · 232210.1039/B601325B ↗
10. Huang L. C. L. · Langmuir · 2004 · 20 · 587910.1021/la0495736 ↗
11. Yang W. S. · Nat. Mater. · 2002 · 1 · 25310.1038/nmat779 ↗
12. Hartl A. · Nat. Mater. · 2004 · 3 · 73610.1038/nmat1204 ↗
13. Kossovsky N. · Bioconjugate Chem. · 1995 · 6 · 50710.1021/bc00035a001 ↗
14. Huang H. · Nano Lett. · 2007 · 7 · 330510.1021/nl071521o ↗
15. Schrand A. M. · J. Phys. Chem. B · 2007 · 111 · 210.1021/jp066387v ↗
16. Boussif O. · Proc. Natl. Acad. Sci. U.S.A · 1995 · 92 · 729710.1073/pnas.92.16.7297 ↗
17. Zhang X. Q. · Biomaterials · 2009 · 30 · 263210.1016/j.biomaterials.2009.01.021 ↗
18. Zhang X. Q. · Biomacromolecules · 2005 · 6 · 34110.1021/bm040060n ↗
19. Akinc A. · J. Gene Med. · 2005 · 7 · 65710.1002/jgm.696 ↗
20. Fischer D. · Pharm. Res. · 1999 · 16 · 127310.1023/A:1014861900478 ↗
21. Petersen H. · Biomacromolecules · 2002 · 3 · 92610.1021/bm025539z ↗
22. Gosselin M. A. · Bioconjugate Chem. · 2001 · 12 · 98910.1021/bc0100455 ↗
23. Kong X. L. · Anal. Chem. · 2005 · 77 · 427310.1021/ac050213c ↗
24. Fu C. C. · Proc. Natl. Acad. Sci. U.S.A · 2007 · 104 · 72710.1073/pnas.0605409104 ↗
25. Kostarelos K. · Nat. Nanotechnol. · 2007 · 2 · 10810.1038/nnano.2006.209 ↗
26. Lal S. · Acc. Chem. Res. · 2008 · 41 · 184210.1021/ar800150g ↗
27. Chang Y. R. · Nat. Nanotechnol. · 2008 · 3 · 28410.1038/nnano.2008.99 ↗
28. Gobin A. M. · Nano Lett. · 2007 · 7 · 192910.1021/nl070610y ↗
29. Qian X. M. · Nat. Biotechnol. · 2008 · 26 · 8310.1038/nbt1377 ↗
30. Peer D. · Nat. Nanotechnol. · 2007 · 2 · 75110.1038/nnano.2007.387 ↗
31. Guan J. J. · Proc. Natl. Acad. Sci. U.S.A. · 2005 · 102 · 1832110.1073/pnas.0506902102 ↗
32. Dennis A. M. · Nano Lett. · 2008 · 8 · 143910.1021/nl080358+ ↗
33. Hauck T. S. · Adv. Mater. · 2008 · 20 · 383210.1002/adma.200800921 ↗
34. Mochalin V. N. · J. Am. Chem. Soc. · 2009 · 131 · 459410.1021/ja9004514 ↗
35. Liu Z. · Cancer Res. · 2008 · 68 · 665210.1158/0008-5472.CAN-08-1468 ↗
36. Ajima K. · Mol. Pharmaceutics · 2005 · 2 · 47510.1021/mp0500566 ↗
37. Yeap W. S. · Anal. Chem. · 2008 · 80 · 465910.1021/ac800009v ↗
38. Skrabalak S. E. · Adv. Mater. · 2007 · 19 · 317710.1002/adma.200701972 ↗
39. Bunimovich Y. L. · J. Am. Chem. Soc. · 2006 · 128 · 1632310.1021/ja065923u ↗
40. Zhang C. Y. · Nat. Mater. · 2005 · 4 · 82610.1038/nmat1508 ↗
41. Fu A. H. · Nano Lett. · 2007 · 7 · 17910.1021/nl0626434 ↗
42. Alivisatos A. P. · Annu. Rev. Biomed. Eng. · 2005 · 7 · 5510.1146/annurev.bioeng.7.060804.100432 ↗
43. Fu A. H. · Curr. Opin. Neurobiol. · 2005 · 15 · 56810.1016/j.conb.2005.08.004 ↗
44. Fu A. H. · J. Am. Chem. Soc. · 2004 · 126 · 1083210.1021/ja046747x ↗
45. Alivisatos P. · Nat. Biotechnol. · 2004 · 22 · 4710.1038/nbt927 ↗
46. Tisler J. · ACS Nano · 2009 · 3 · 195910.1021/nn9003617 ↗
47. Balasubramanian G. · Nature · 2008 · 455 · 64810.1038/nature07278 ↗
48. Balasubramanian G. · Nat. Mater. · 2009 · 8 · 38310.1038/nmat2420 ↗
49. Barnard A. S. · J. Mater. Chem. · 2007 · 17 · 481110.1039/b710189a ↗
50. Krueger A. · Chem.—Eur. J. · 2008 · 14 · 138210.1002/chem.200700987 ↗